Page 3 - Aav Platform News Today

In what it says marks an industry first, Luxembourg-based Canal+ pay-TV firm M7 Group is to integrate its TV platforms into smart TV sets from leading manufactu...

Leading Malaysian content and entertainment company Astro has chosen Kaltura TV Platform to power sooka, its standalone streaming service offering that is targe...

As it enhances is GigaTV service - including carrier-grade CDN, origin server and video personalisation –  Germany’s largest cable operator Vodafone Deutsc...

Biogen and Ginkgo Bioworks say their collaboration and license agreement will develop a next-generation AAV production platform, aiming to ‘redefine the industry standard for manufacturing recombinant adeno-associated virus (AAV)-based vectors’.

| 03 May 2021 Marking the launch of its flagship movie brand in the Netherlands, SPI International has extended the reach of the FilmBox service in Western Europe, making it available to satellite and IP-based TV platform M7 Group. FilmBox will initially launch on 4 May to the basic package subscribers of the DTH and IPTV platforms of M7’s pay-TV platform Canal Digitaal. FilmBox offers a slate of Hollywood movies, evergreens and popular series to over 30 million households global...

New preclinical research, published in Nature, suggests a new avenue for Alzheimer’s disease (AD) treatment, through restoring lymphatic flow in the brain

Neurogene in tie up with university to advance gene therapy technologies New York based, Neurogene, has announced a research collaboration with the University of Edinburgh for the development of a multiple-platform approach to diseases not addressable by conventional gene therapy. However, the partners were not willing to disclose, as of today, which diseases exactly are being targeted under this alliance. The collaborative project combines Neurogene’s manufacturin...

New antibody discovery platform could help accelerate CAR-T therapeutic development In a paper published in the Journal of Biological Chemistry​​​, OXGENE scientists used the self-labelling integral membrane (SLIM) protein discovery system to identify a panel of novel antibodies against the oncogenic target epithelial cell adhesion molecule, which remained in its native configuration within the cell membrane. They said they were able to further demonstrate the functionality of these anti...